BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7525263)

  • 21. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
    Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
    Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
    Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
    J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
    Neely EK; Rosenfeld RG
    Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4.
    Ceda GP; Fielder PJ; Henzel WJ; Louie A; Donovan SM; Hoffman AR; Rosenfeld RG
    Endocrinology; 1991 Jun; 128(6):2815-24. PubMed ID: 1709857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation.
    Irwin JC; Suen LF; Faessen GH; Popovici RM; Giudice LC
    J Clin Endocrinol Metab; 2001 May; 86(5):2060-4. PubMed ID: 11344207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast.
    Kiefer MC; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz FR; Green K; Barr PJ; Zapf J
    J Biol Chem; 1992 Jun; 267(18):12692-9. PubMed ID: 1377672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
    Foulstone EJ; Meadows KA; Holly JM; Stewart CE
    J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
    Yeh LC; Adamo ML; Olson MS; Lee JC
    Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T; Busby W; Clemmons DR
    Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
    Durham SK; Riggs BL; Conover CA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk.
    Ho PJ; Baxter RC
    Endocrinology; 1997 Sep; 138(9):3811-8. PubMed ID: 9275069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins.
    McCusker RH; Busby WH; Dehoff MH; Camacho-Hubner C; Clemmons DR
    Endocrinology; 1991 Aug; 129(2):939-49. PubMed ID: 1713163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
    Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
    J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
    Irwin JC; Dsupin BA; Giudice LC
    J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative feedback regulation of insulin-like growth factor-II gene expression in differentiating myoblasts in vitro.
    Magri KA; Benedict MR; Ewton DZ; Florini JR
    Endocrinology; 1994 Jul; 135(1):53-62. PubMed ID: 8013391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.
    Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
    J Biol Chem; 1993 May; 268(13):9246-54. PubMed ID: 7683646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins.
    Roghani M; Lassarre C; Zapf J; Povoa G; Binoux M
    J Clin Endocrinol Metab; 1991 Sep; 73(3):658-66. PubMed ID: 1714916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
    Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.